Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ursodeoxycholic Acid (450mg) SR
Therapeutic Category
Gastroenterology, General and OTC medicines, Hepatology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹557/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Uriviga SR 450 Tablet contains Ursodeoxycholic Acid (UDCA), a naturally occurring bile acid that is primarily used to treat liver and biliary disorders. It works by reducing the amount of cholesterol absorbed by the liver and helps in breaking down cholesterol stones in the gallbladder. Ursodeoxycholic Acid is commonly prescribed for patients suffering from primary biliary cirrhosis, gallstones, and liver diseases related to the biliary system. This formulation is sustained-release (SR), allowing for gradual absorption over time and helping to maintain stable therapeutic levels.
Uriviga SR 450 provides support in managing cholestatic liver diseases, reduces the risk of gallstone formation, and aids in the improvement of liver function. It is also helpful in patients undergoing gallbladder stone dissolution therapy, providing a non-invasive alternative to surgery.
Possible side effects include nausea, diarrhea, abdominal pain, and headache. Serious side effects may include liver function changes or allergic reactions.
Indicated for the treatment of primary biliary cirrhosis, gallstones, and liver disorders associated with cholestasis.
Consult your healthcare provider before use if you have liver or kidney disease. Monitor liver function during therapy.
Store in a cool, dry place at room temperature. Keep away from direct sunlight and out of reach of children.
Composition : Ursodeoxycholic Acid (600mg) SR
Composition : Ursodeoxycholic Acid (300mg)
Composition : Ursodeoxycholic Acid (150mg)
Composition : Ursodeoxycholic Acid (125mg/5ml)
Composition : Sodium Bicarbonate (500mg)
Composition : Sodium Bicarbonate (1000mg)
Composition : Obeticholic acid (5mg) Tablet
Composition : Obeticholic acid (10mg) Tablet
Composition : Rabeprazole (20mg)
Composition : Lansoprazole (30mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Uriviga SR 450 Tablet has increasing demand in the urology and urinary health segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their business in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for Uriviga SR 450 Tablet in urinary tract and urology care segments. Including this product helps strengthen their specialty medicine and urology product portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Uriviga SR 450 Tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable product supply for distributors and medical agencies.
Wholesalers and medical agencies benefit from attractive business margins, timely product availability, professional marketing support, and access to a trusted urology pharmaceutical range when partnering with Cafoli Lifecare for Uriviga SR 450 Tablet distribution.
Medical distributors, stockists, wholesalers, and pharma professionals interested in Uriviga SR 450 Tablet can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.